Castle Biosciences CSTL
NASDAQ CSTL
$34.24 +0.15 (+0.45%)
As of: Aug 27, 2026 · 3:59 PM EDT

Castle Biosciences (CSTL) Acquisitions (2022)

Castle Biosciences (CSTL) posted Acquisitions of $305000.0 for Q3 2022.

Castle Biosciences (CSTL) Acquisitions (2022) Analysis & Trends

Castle Biosciences has reported Acquisitions for 1 years, with the latest figure at $305000.0 in Q3 2022.

  • Quarterly Acquisitions changed N/A year-over-year to $305000.0 in Q3 2022, while the trailing twelve-month figure through Dec 2023 was $305000.0 (changed 0.0% YoY) and the FY2022 annual result came in at $27.0 million, changed N/A from the prior year.
  • Acquisitions was little changed at $305000.0 in Q3 2022 per CSTL's latest filing.
  • Over five years, Acquisitions peaked at $305000.0 in Q3 2022 and troughed at $305000.0 in Q3 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Thermo Fisher Scientific 234.15 Bn 230.09 Bn 8.34 Bn -
2 Danaher 152.10 Bn 147.75 Bn 3.61 Bn -
3 Natera 48.48 Bn 47.38 Bn 486.15 Mn -
4 Agilent Technologies 44.35 Bn 42.55 Bn 990.00 Mn -
5 Iqvia Holdings 43.68 Bn 41.60 Bn 1.44 Bn 163.00 Mn
6 Idexx Laboratories 43.02 Bn 42.83 Bn 779.09 Mn -
7 Illumina 34.39 Bn 33.22 Bn 770.00 Mn 2.00 Mn
8 Mettler Toledo International 28.29 Bn 28.24 Bn 650.22 Mn -
9 Labcorp Holdings 27.51 Bn 27.37 Bn 1.11 Bn 225.70 Mn
10 Castle Biosciences 1.04 Bn 773.13 Mn 79.85 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2022 305,000.00